BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8746042)

  • 1. [Crohn disease, hemorrhagic rectocolitis: antibodies and humans].
    Duclos B
    Gastroenterol Clin Biol; 1995 Nov; 19(11):865-6. PubMed ID: 8746042
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunology of inflammatory bowel disease.
    Stenson WF; MacDermott RP
    Year Immunol; 1989; 4():286-95. PubMed ID: 2648705
    [No Abstract]   [Full Text] [Related]  

  • 3. Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies: serologic markers in inflammatory bowel disease.
    Hartman C; Eliakim R; Shamir R
    Isr Med Assoc J; 2004 Apr; 6(4):221-6. PubMed ID: 15115261
    [No Abstract]   [Full Text] [Related]  

  • 4. [Importance of ANCAs in the pathogenesis of chronic inflammatory bowel diseases].
    Müller-Ladner U; Andus T; Lang B; Gross V
    Verh Dtsch Ges Pathol; 1996; 80():215. PubMed ID: 9065008
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum antibodies for the diagnosis of inflammatory bowel disease: ANCA for ulcerative colitis and ASCA for Crohn's disease.
    Tecnologica MAP Suppl; 1999 Jun; ():18-20. PubMed ID: 10848041
    [No Abstract]   [Full Text] [Related]  

  • 6. T cell apoptosis and inflammatory bowel disease.
    Peppelenbosch MP; van Deventer SJ
    Gut; 2004 Nov; 53(11):1556-8. PubMed ID: 15479669
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunologic methods in diagnosis of inflammatory bowel disease].
    Macura-Biegun A; Błaut A
    Przegl Lek; 2002; 59(6):468-71. PubMed ID: 12418289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing between anti-neutrophil cytoplasmic antibody patterns in inflammatory bowel disease: is the "atypical pattern" adding more information?
    Barahona-Garrido J; Hernández-Calleros J; Cabiedes J; Sarti HM; Torre A; Montaño-Loza AJ; Yamamoto-Furusho JK
    Am J Gastroenterol; 2009 Jul; 104(7):1854-5. PubMed ID: 19574983
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunology of inflammatory bowel disease--an update.
    Jewell DP
    J Gastroenterol; 1995 Nov; 30 Suppl 8():78-82. PubMed ID: 8563898
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of 4C8 antigen, a novel transendothelial migration-associated molecule on activated T lymphocytes, in inflammatory bowel disease.
    Oshitani N; Hato F; Kitagawa S; Masuyama J; Higuchi K; Matsumoto T; Arakawa T
    J Pathol; 2002 Aug; 197(5):589-94. PubMed ID: 12210077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autoantibodies in chronic inflammatory bowel diseases: more than an epiphenomenon?].
    Folwaczny C; Fricke H
    Z Gastroenterol; 1998 Jan; 36(1):105-8. PubMed ID: 9531690
    [No Abstract]   [Full Text] [Related]  

  • 12. [Characteristics of lymphocyte populations and macrophages of the lamina propria in chronic inflammatory bowel disease. The role of cytokines].
    Gayá A
    Gastroenterol Hepatol; 1995 Dec; 18(10):510-4. PubMed ID: 8548587
    [No Abstract]   [Full Text] [Related]  

  • 13. Autoimmune factors in inflammatory bowel disease.
    Solomon GE
    Mt Sinai J Med; 1976; 43(5):602-24. PubMed ID: 792686
    [No Abstract]   [Full Text] [Related]  

  • 14. Serological markers (anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic antibodies) in inflammatory bowel disease: diagnostic utility and phenotypic correlation.
    Buckland MS; Mylonaki M; Rampton D; Longhurst HJ
    Clin Diagn Lab Immunol; 2005 Nov; 12(11):1328-30. PubMed ID: 16275949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
    Mokrowiecka A; Gasiorowska A; Małecka-Panas E
    Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Course of cellular immunity in patients with chronic inflammatory intestinal disease].
    Velo Bellver JL; Martínez Prieto C; Sebastián Domingo J; Bañares Cañizares R; Clemente Ricote G; Medina MC; Alcalá Santaella R
    Rev Esp Enferm Apar Dig; 1989 Jun; 75(6 Pt 1):572-6. PubMed ID: 2762639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease.
    Caradonna L; Amati L; Lella P; Jirillo E; Caccavo D
    Am J Gastroenterol; 2000 Jun; 95(6):1495-502. PubMed ID: 10894586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetics and immunopathogenesis of inflammatory bowel disease.
    Cho JH
    Nat Rev Immunol; 2008 Jun; 8(6):458-66. PubMed ID: 18500230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the innate immune system in the pathogenesis of inflammatory bowel disease.
    van Lierop PP; Samsom JN; Escher JC; Nieuwenhuis EE
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):142-51. PubMed ID: 19179875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunologic findings in patients with chronic inflammatory bowel diseases. Crohn disease and ulcerative colitis].
    Remvig L; Davidsen B; Kristensen E
    Ugeskr Laeger; 1983 Apr; 145(17):1289-93. PubMed ID: 6349067
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.